Evidence map›Paper›PMID 19897683›Full record

ArticleThe Journal of clinical endocrinology and metabolism2010

Thyroid hormone induced brown adipose tissue and amelioration of diabetes in a patient with extreme insulin resistance.

Monica C Skarulis, Francesco S Celi, Elisabetta Mueller, Marina Zemskova, Rana Malek, Lynne Hugendubler, Craig Cochran, Jeffrey Solomon, Clara Chen, Phillip Gorden

2 registry-linked trialsOpen access · greenAbstract readCase Reports
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 76 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed, 2 pooled it
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02457897 phase2completednot on this mapstarted 2015, after this paper: background citation

Thyroid Hormone to Induce Non-Insulin Mediated Glucose Disposal in Patients With Insulin Receptor Mutations

TypeinterventionalSponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Ran2015 to 2018Enrolled7ConditionsInsulin Resistance, Diabetes Mellitus, Abnormal Glucose MetabolismArmsLiothyronine
NCT02499471 nacompletednot on this mapstarted 2012, after this paper: background citation

Brown Adipose Tissue Activity and Thyroid Hormone

TypeinterventionalSponsorMaastricht University Medical CenterRan2012 to 2014Enrolled12ConditionsHypothyroidism, Hyperthyroidism, ObesityArmsLevothyroxine therapy (137.75 ± 23.75 μg/day)
3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 2 syntheses or guidelines pooled it, 159 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Thyroid Hormone Effects on Glucose Disposal in Patients With Insulin Receptor Mutations.The Journal of clinical endocrinology and metabolism · 2020
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Metreleptin improves blood glucose in patients with insulin receptor mutations.The Journal of clinical endocrinology and metabolism · 2013
    Trial
  9. Trial
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Inter-Organ Communication Involved in Brown Adipose Tissue Thermogenesis.Advances in experimental medicine and biology · 2024
    Review
  16. Review
  17. Article
  18. Article
  19. [New development for targeted therapy of non-alcoholic fatty liver disease with thyroid hormone receptor beta].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2021
    Article
  20. Review

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Monica C SkarulisClinical Endocrine Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland 20892-1613, USA. monica_skarulis@nih.gov
Francesco S Celi
Elisabetta Mueller
Marina Zemskova
Rana Malek
Lynne Hugendubler
Craig Cochran
Jeffrey Solomon
Clara Chen
Phillip Gorden
National Institute of Diabetes and Digestive and Kidney Diseases · USNational Institutes of Health Clinical Center · US

Funding

The NIH Inter-Institute Training Program in Endocrinology, Diabetes & MetabolismZIEDK075100 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI MUNIYAPPA, RANGANATH · 2009 to 2025
$18.0M
Biobehavioral Studies of Obesity, Weight loss and RecidivismZIADK075007 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI MUNIYAPPA, RANGANATH · 2009 to 2025
$13.8M
Molecular and Clinical Studies of Insulin ResistanceZIADK047050 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI BROWN, REBECCA · 2009 to 2025
$6.1M
Studies of Benign and Malignant Thyroid DiseaseZIADK047053 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI KLUBO-GWIEZDZINSKA, JOANNA · 2009 to 2025
$4.3M
Identification of novel transcriptional regulators of lipid metabolism.ZIADK056023 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI MUELLER, ELISABETTA · 2009 to 2016
$3.9M
Thyroid hormone action on glucose and energy metabolism in vivo studiesZIADK047057 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI CELI, FRANCESCO S · 2009 to 2013
$2.8M
Thyroid hormone conversion in vitro and ex vivo studiesZIADK075001 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI CELI, FRANCESCO S · 2009 to 2013
$2.7M
Studies of Thyroid Function in Health and DiseaseZ01DK075005 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI SKARULIS, MONICA · 2005 to 2008
$965k
Thyroid hormone action on glucose and energy metabolism in vivo studiesZ01DK047057 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI CELI, FRANCESCO S · 2008 to 2008
$481k
Intramural NIH HHS Z01 DK075005NIDDK NIH HHS Z01-DK047057-01NIDDK NIH HHS Z01 DK075005-04
6 · The paper itself

Abstract

contextBrown adipose tissue (BAT) found by positron emission/computed tomography (PET-CT) using flouro-deoxyglucose (FDG) is inducible by cold exposure in men. Factors leading to increased BAT are of great interest for its potential role in the treatment of diabetes and obesity.

objectiveWe tested whether thyroid hormone (TH) levels are related to the volume and activity of BAT in a patient with a mutation in the insulin receptor gene. DESIGN/SETTING/

interventionOur work was based on the case report of a patient in an observational study at the National Institutes of Health. PATIENT: The patient discontinued insulin and oral antidiabetics after thyroidectomy and suppressive-dose levothyroxine therapy for thyroid cancer. PET-CT uptake in BAT was confirmed by histology and molecular analysis. OUTCOMES: PET-CT studies were performed, and we measured hemoglobin A1c and resting energy expenditure before and after levothyroxine discontinuation for thyroid cancer testing. Molecular studies of BAT and white adipose samples are presented.

resultSupraclavicular and periumbilical sc adipose tissue demonstrated molecular features of BAT including uncoupling protein-1, type 2 deiodinase, and PR domain containing 16 by quantitative PCR. Activity of type 2 deiodinase activity was increased. The discontinuation of levothyroxine resulted in decreased FDG uptake and diminished volume of BAT depots accompanied by worsening of diabetic control.

conclusionsThis case demonstrates the TH effect on BAT activity and volume in this patient and an association between BAT activity and glucose levels in this patient. Because the contribution of TH on skeletal muscle energy expenditure and fuel metabolism was not assessed, an association between BAT activity and glucose homeostasis can only be suggested.

Indexed as

Insulin ResistanceAdipose Tissue, BrownAdultCell ProliferationDiabetes MellitusFemaleFollow-Up StudiesHumansOrgan SizeReceptor, InsulinThyroid HormonesReceptor, InsulinThyroid Hormones

Identifiers

PMID19897683
PMCPMC2805496
OpenAlexW2139337228

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.